# FDA Inspection 1301396 - Biomat USA, Inc. - March 25, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/b7414035-d73b-4480-aca5-000031ebe44e
Source feed: FDA_Inspections

> FDA Inspection 1301396 for Biomat USA, Inc. on March 25, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1301396
- Company Name: Biomat USA, Inc.
- Inspection Date: 2026-03-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1315908 - 2026-04-15](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/7b31e38d-801a-4223-9fd4-784dd1b857fd)
- [FDA Inspection 1304374 - 2026-02-05](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/8aa91d22-578e-42cb-bc42-5020b69abca8)
- [FDA Inspection 1297602 - 2025-12-18](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/7b7e2c66-ece8-4688-8604-9b817eaff6ec)
- [FDA Inspection 1256778 - 2024-11-27](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/0787c83f-95bf-462d-87f8-8afb4347c03b)
- [FDA Inspection 1256778 - 2024-11-27](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/bb9e80a6-12c4-49e9-813b-e0d1e16331f0)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/fb86256a-4537-4354-b11d-6183c8a5a2c3

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d